ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

103 hedge funds and large institutions have $353M invested in Albireo Pharma, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 33 reducing their positions, and 21 closing their positions.

Holders
103
Holders Change
-6
Holders Change %
-5.5%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
18
Increased
37
Reduced
33
Closed
21
Calls
$2.49M
Puts
$863K
Net Calls
+$1.63M
Net Calls Change
-$6.31M

Top Buyers

1
State Street
1
State Street
Massachusetts
$28.3M
2
Franklin Resources
2
Franklin Resources
California
$17.3M
3
CC
3
Chicago Capital
Illinois
$26.8M
4
TCM
4
Tang Capital Management
California
$13.9M
5
JGC
5
J. Goldman & Co
New York
$4.59M

Top Sellers

1
O
1
OrbiMed
New York
$0
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
Federated Hermes
3
Federated Hermes
Pennsylvania
$44.8M
4
SCM
4
Sio Capital Management
New York
$1.16M
5
ECM
5
Endurant Capital Management
California
$751K
Name Market Value Shares Shares
Change 		Shares
Change %
GWS
126
Glassman Wealth Services
Virginia
$0 9 +9 New
Goldman Sachs
127
Goldman Sachs
New York
$0 76,689 +33,362 +77%
2 3 4 5
6